GCP
VTAE

GSA Capital Partners’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

GSA Capital Partners’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-68,877
Closed -$807K – 2345
2015
Q1 		$807K Buy
+68,877
New +$929K 0.03% 1042

Other funds holding VTAE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GSA Capital Partners's VTAE Position: Q2 2015 in Review

GSA Capital Partners sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q2 2015, closing a stake of 68,877 shares — an estimated $807K sold.

GSA Capital Partners first reported a position in VTAE in Q1 2015 and held it in 1 quarter. The position peaked at $807K in Q1 2015. 53 funds tracked by Wall St. Rank hold VTAE as of Q2 2015.

  • GSA Capital Partners reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q2 2015 after selling out during the quarter.
  • GSA Capital Partners sold 68,877 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q2 2015, an estimated $807K.
  • GSA Capital Partners first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q1 2015 and held it in 1 quarter.
  • GSA Capital Partners's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $807K in Q1 2015.
  • 53 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q2 2015.

Based on GSA Capital Partners's 13F filing for Q2 2015, filed 14 Aug 2015.